Global Hepatitis A Vaccine Market Insights, Forecast to 2028

Global Hepatitis A Vaccine Market Insights, Forecast to 2028

Table of Contents
1 STUDY COVERAGE 1
1.1 Hepatitis A Vaccine Product Introduction 1
1.2 Market by Type 2
1.2.1 Global Hepatitis A Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 2
1.2.2 Inactivated Vaccine 4
1.2.3 Live Attenuated Vaccine 5
1.3 Market by Application 5
1.4 Study Objectives 7
1.5 Years Considered 8
2 EXECUTIVE SUMMARY 9
2.1 Global Hepatitis A Vaccine Sales Estimates and Forecasts 2017-2028 9
2.2 Global Hepatitis A Vaccine Revenue Estimates and Forecasts 2017-2028 10
2.3 Global Hepatitis A Vaccine Revenue by Region: 2017 VS 2021 VS 2028 11
2.4 Global Hepatitis A Vaccine Sales by Region 13
2.4.1 Global Hepatitis A Vaccine Sales by Region (2017-2022) 13
2.4.2 Global Sales Hepatitis A Vaccine by Region (2023-2028) 14
2.5 Global Hepatitis A Vaccine Revenue by Region 15
2.5.1 Global Hepatitis A Vaccine Revenue by Region (2017-2022) 15
2.5.2 Global Hepatitis A Vaccine Revenue by Region (2023-2028) 16
2.6 North America 17
2.7 Europe 18
2.8 Asia-Pacific 19
2.9 South America 20
2.10 Middle East & Africa 21
3 COMPETITION BY MANUFACTURERS 23
3.1 Global Hepatitis A Vaccine Sales by Manufacturers 23
3.1.1 Global Hepatitis A Vaccine Sales by Manufacturers (2020-2022) 23
3.1.2 Global Hepatitis A Vaccine Sales Market Share by Manufacturers (2020-2022) 24
3.1.3 Global Top Largest Manufacturers of Hepatitis A Vaccine in 2021 24
3.2 Global Hepatitis A Vaccine Revenue by Manufacturers 25
3.2.1 Global Hepatitis A Vaccine Revenue by Manufacturers (2020-2022) 25
3.2.2 Global Hepatitis A Vaccine Revenue Market Share by Manufacturers (2020-2022) 26
3.2.3 Global Top Companies by Hepatitis A Vaccine Revenue in 2021 26
3.3 Global Hepatitis A Vaccine Sales Price by Manufacturers (2020-2022) 27
3.4 Analysis of Competitive Landscape 28
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 28
3.4.2 Global Hepatitis A Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) 29
3.4.3 Global Hepatitis A Vaccine Manufacturers Geographical Distribution 29
3.5 Mergers & Acquisitions, Expansion Plans 31
4 MARKET SIZE BY TYPE 33
4.1 Global Hepatitis A Vaccine Sales by Type 33
4.1.1 Global Hepatitis A Vaccine Historical Sales by Type (2017-2022) 33
4.1.2 Global Hepatitis A Vaccine Forecasted Sales by Type (2023-2028) 33
4.1.3 Global Hepatitis A Vaccine Sales Market Share by Type (2017-2028) 33
4.2 Global Hepatitis A Vaccine Revenue by Type 34
4.2.1 Global Hepatitis A Vaccine Historical Revenue by Type (2017-2022) 34
4.2.2 Global Hepatitis A Vaccine Forecasted Revenue by Type (2023-2028) 35
4.2.3 Global Hepatitis A Vaccine Revenue Market Share by Type (2017-2028) 35
4.3 Global Hepatitis A Vaccine Price by Type 36
4.3.1 Global Hepatitis A Vaccine Price by Type (2017-2022) 36
4.3.2 Global Hepatitis A Vaccine Price Forecast by Type (2023-2028) 36
5 MARKET SIZE BY APPLICATION 37
5.1 Global Hepatitis A Vaccine Sales by Application 37
5.1.1 Global Hepatitis A Vaccine Historical Sales by Application (2017-2022) 37
5.1.2 Global Hepatitis A Vaccine Forecasted Sales by Application (2023-2028) 37
5.1.3 Global Hepatitis A Vaccine Sales Market Share by Application (2017-2028) 37
5.2 Global Hepatitis A Vaccine Revenue by Application 38
5.2.1 Global Hepatitis A Vaccine Historical Revenue by Application (2017-2022) 38
5.2.2 Global Hepatitis A Vaccine Forecasted Revenue by Application (2023-2028) 39
5.2.3 Global Hepatitis A Vaccine Revenue Market Share by Application (2017-2028) 39
5.3 Global Hepatitis A Vaccine Price by Application 40
5.3.1 Global Hepatitis A Vaccine Price by Application (2017-2022) 40
5.3.2 Global Hepatitis A Vaccine Price Forecast by Application (2023-2028) 41
6 NORTH AMERICA 42
6.1 North America Hepatitis A Vaccine Market Size by Type 42
6.1.1 North America Hepatitis A Vaccine Sales by Type (2017-2028) 42
6.1.2 North America Hepatitis A Vaccine Revenue by Type (2017-2028) 43
6.2 North America Hepatitis A Vaccine Market Size by Application 44
6.3 North America Hepatitis A Vaccine Sales by Country 45
6.3.1 North America Hepatitis A Vaccine Sales by Country (2017-2028) 45
6.3.2 North America Hepatitis A Vaccine Revenue by Country (2017-2028) 46
6.3.3 U.S. 47
6.3.4 Canada 47
6.3.5 Mexico 48
7 EUROPE 49
7.1 Europe Hepatitis A Vaccine Market Size by Type 49
7.1.1 Europe Hepatitis A Vaccine Sales by Type (2017-2028) 49
7.1.2 Europe Hepatitis A Vaccine Revenue by Type (2017-2028) 50
7.2 Europe Hepatitis A Vaccine Market Size by Application 51
7.3 Europe Hepatitis A Vaccine Market Size by Country 52
7.3.1 Europe Hepatitis A Vaccine Sales by Country (2017-2028) 52
7.3.2 Europe Hepatitis A Vaccine Revenue by Country (2017-2028) 53
7.3.3 Germany 55
7.3.4 France 55
7.3.5 U.K. 56
7.3.6 Italy 56
7.3.7 Russia 57
8 ASIA PACIFIC 58
8.1 Asia Pacific Hepatitis A Vaccine Market Size by Type 58
8.1.1 Asia Pacific Hepatitis A Vaccine Sales by Type (2017-2028) 58
8.1.2 Asia Pacific Hepatitis A Vaccine Revenue by Type (2017-2028) 59
8.2 Asia Pacific Hepatitis A Vaccine Market Size by Application 60
8.3 Asia Pacific Hepatitis A Vaccine Market Size by Region 61
8.3.1 Asia Pacific Hepatitis A Vaccine Sales by Region (2017-2028) 61
8.3.2 Asia Pacific Hepatitis A Vaccine Revenue by Region (2017-2028) 62
8.3.3 China 64
8.3.4 Japan 64
8.3.5 South Korea 65
8.3.6 India 65
8.3.7 Australia 66
8.3.8 Southeast Asia 66
9 SOUTH AMERICA 67
9.1 South America Hepatitis A Vaccine Market Size by Type 67
9.1.1 South America Hepatitis A Vaccine Sales by Type (2017-2028) 67
9.1.2 South America Hepatitis A Vaccine Revenue by Type (2017-2028) 68
9.2 South America Hepatitis A Vaccine Market Size by Application 69
9.3 South America Hepatitis A Vaccine Market Size by Country 70
9.3.1 South America Hepatitis A Vaccine Sales by Country (2017-2028) 70
9.3.2 South America Hepatitis A Vaccine Revenue by Country (2017-2028) 71
9.3.3 Brazil 72
10 MIDDLE EAST AND AFRICA 73
10.1 Middle East and Africa Hepatitis A Vaccine Market Size by Type 73
10.1.1 Middle East and Africa Hepatitis A Vaccine Sales by Type (2017-2028) 73
10.1.2 Middle East and Africa Hepatitis A Vaccine Revenue by Type (2017-2028) 74
10.2 Middle East and Africa Hepatitis A Vaccine Market Size by Application 75
10.3 Middle East and Africa Hepatitis A Vaccine Market Size by Country 76
10.3.1 Middle East and Africa Hepatitis A Vaccine Sales by Country (2017-2028) 76
10.3.2 Middle East and Africa Hepatitis A Vaccine Revenue by Country (2017-2028) 77
10.3.3 Middle East 78
10.3.4 Africa 79
11 CORPORATE PROFILE 80
11.1 GSK 80
11.1.1 GSK Corporation Information 80
11.1.2 GSK Overview 80
11.1.3 GSK Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 81
11.1.4 GSK Hepatitis A Vaccine Product Introduction 81
11.2 Merck 82
11.2.1 Merck Corporation Information 82
11.2.2 Merck Overview 83
11.2.3 Merck Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 84
11.2.4 Merck Hepatitis A Vaccine Product Introduction 84
11.2.5 Merck Recent Developments 85
11.3 Sanofi 86
11.3.1 Sanofi Corporation Information 86
11.3.2 Sanofi Overview 87
11.3.3 Sanofi Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 87
11.3.4 Sanofi Hepatitis A Vaccine Product Introduction 88
11.3.5 Sanofi Recent Developments 89
11.4 Sinovac 90
11.4.1 Sinovac Corporation Information 90
11.4.2 Sinovac Overview 90
11.4.3 Sinovac Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 91
11.4.4 Sinovac Hepatitis A Vaccine Product Introduction 91
11.4.5 Sinovac Recent Developments 92
11.5 Zhejiang Pukang 92
11.5.1 Zhejiang Pukang Corporation Information 92
11.5.2 Zhejiang Pukang Overview 93
11.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 93
11.5.4 Zhejiang Pukang Hepatitis A Vaccine Product Introduction 94
11.6 Changchun Institute of Biological 94
11.6.1 Changchun Institute of Biological Corporation Information 94
11.6.2 Changchun Institute of Biological Overview 95
11.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 96
11.6.4 Changchun Institute of Biological Hepatitis A Vaccine Product Introduction 96
11.7 KM Biologics 97
11.7.1 KM Biologics Corporation Information 97
11.7.2 KM Biologics Overview 97
11.7.3 KM Biologics Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 99
11.7.4 KM Biologics Hepatitis A Vaccine Product Introduction 99
11.7.5 KM Biologics Recent Developments 100
11.8 IMBCAMS 101
11.8.1 IMBCAMS Corporation Information 101
11.8.2 IMBCAMS Overview 101
11.8.3 IMBCAMS Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 102
11.8.4 IMBCAMS Hepatitis A Vaccine Product Introduction 102
11.9 AIM Vaccine 103
11.9.1 AIM Vaccine Corporation Information 103
11.9.2 AIM Vaccine Overview 104
11.9.3 AIM Vaccine Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 105
11.9.4 AIM Vaccine Hepatitis A Vaccine Product Introduction 105
11.9.5 AIM Vaccine Recent Developments 106
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 108
12.1 Hepatitis A Vaccine Industry Chain Analysis 108
12.2 Hepatitis A Vaccine Key Raw Materials 109
12.2.1 Key Raw Materials 109
12.2.2 Raw Materials Key Suppliers 109
12.3 Hepatitis A Vaccine Production Mode & Process 111
12.4 Hepatitis A Vaccine Sales and Marketing 112
12.4.1 Hepatitis A Vaccine Sales Channels 112
12.4.2 Hepatitis A Vaccine Distributors 113
12.5 Hepatitis A Vaccine Customers 115
13 HEPATITIS A VACCINE MARKET DYNAMICS 118
13.1.1 Hepatitis A Vaccine Industry Trends 118
13.1.2 Hepatitis A Vaccine Market Drivers 118
13.1.3 Hepatitis A Vaccine Market Challenges 119
13.1.4 Hepatitis A Vaccine Market Restraints 120
14 KEY FINDINGS IN THE GLOBAL HEPATITIS A VACCINE STUDY 121
15 APPENDIX 123
15.1 Research Methodology 123
15.1.1 Methodology/Research Approach 123
15.1.2 Data Source 126
15.2 Author Details 129
15.3 Disclaimer 129
List of Tables
Table 1. Global Hepatitis A Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) 2
Table 2. Major Manufacturers of Live Attenuated Vaccine 5
Table 3. Global Hepatitis A Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) 6
Table 4. Global Hepatitis A Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) 11
Table 5. Global Hepatitis A Vaccine Sales by Region (2017-2022) & (K Unit) 13
Table 6. Global Hepatitis A Vaccine Sales Market Share by Region (2017-2022) 13
Table 7. Global Hepatitis A Vaccine Sales by Region (2023-2028) & (K Unit) 14
Table 8. Global Hepatitis A Vaccine Sales Market Share by Region (2023-2028) 14
Table 9. Global Hepatitis A Vaccine Revenue by Region (2017-2022) & (US$ Million) 15
Table 10. Global Hepatitis A Vaccine Revenue Market Share by Region (2017-2022) 16
Table 11. Global Hepatitis A Vaccine Revenue by Region (2023-2028) & (US$ Million) 16
Table 12. Global Hepatitis A Vaccine Revenue Market Share by Region (2023-2028) 16
Table 13. Global Hepatitis A Vaccine Sales by Manufacturers (2020-2022) & (K Unit) 23
Table 14. Global Hepatitis A Vaccine Sales Share by Manufacturers (2020-2022) 24
Table 15. Global Hepatitis A Vaccine Revenue by Manufacturers (2020-2022) & (US$ Million) 25
Table 16. Global Hepatitis A Vaccine Revenue Market Share by Manufacturers (2020-2022) 26
Table 17. Hepatitis A Vaccine Price by Manufacturers (2020-2022) & (USD/Unit) 27
Table 18. Global Hepatitis A Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) 28
Table 19. Global Hepatitis A Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A Vaccine as of 2021) 29
Table 20. Hepatitis A Vaccine Manufacturing Base Distribution and Headquarters 29
Table 21. Manufacturers Hepatitis A Vaccine Product Offered 30
Table 22. Date of Manufacturers Enter into Hepatitis A Vaccine Market 30
Table 23. Mergers & Acquisitions, Expansion Plans 31
Table 24. Global Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit) 33
Table 25. Global Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit) 33
Table 26. Global Hepatitis A Vaccine Sales Share by Type (2017-2022) 33
Table 27. Global Hepatitis A Vaccine Sales Share by Type (2023-2028) 34
Table 28. Global Hepatitis A Vaccine Revenue by Type (2017-2022) & (US$ Million) 34
Table 29. Global Hepatitis A Vaccine Revenue by Type (2023-2028) & (US$ Million) 35
Table 30. Global Hepatitis A Vaccine Revenue Share by Type (2017-2022) 35
Table 31. Global Hepatitis A Vaccine Revenue Share by Type (2023-2028) 35
Table 32. Hepatitis A Vaccine Price by Type (2017-2022) & (USD/Unit) 36
Table 33. Global Hepatitis A Vaccine Price Forecast by Type (2023-2028) & (USD/Unit) 36
Table 34. Global Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit) 37
Table 35. Global Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit) 37
Table 36. Global Hepatitis A Vaccine Sales Share by Application (2017-2022) 37
Table 37. Global Hepatitis A Vaccine Sales Share by Application (2023-2028) 38
Table 38. Global Hepatitis A Vaccine Revenue by Application (2017-2022) & (US$ Million) 38
Table 39. Global Hepatitis A Vaccine Revenue by Application (2023-2028) & (US$ Million) 39
Table 40. Global Hepatitis A Vaccine Revenue Share by Application (2017-2022) 39
Table 41. Global Hepatitis A Vaccine Revenue Share by Application (2023-2028) 39
Table 42. Hepatitis A Vaccine Price by Application (2017-2022) & (USD/Unit) 40
Table 43. Global Hepatitis A Vaccine Price Forecast by Application (2023-2028) & (USD/Unit) 41
Table 44. North America Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit) 42
Table 45. North America Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit) 42
Table 46. North America Hepatitis A Vaccine Revenue by Type (2017-2022) & (US$ Million) 43
Table 47. North America Hepatitis A Vaccine Revenue by Type (2023-2028) & (US$ Million) 43
Table 48. North America Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit) 44
Table 49. North America Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit) 44
Table 50. North America Hepatitis A Vaccine Sales by Country (2017-2022) & (K Unit) 45
Table 51. North America Hepatitis A Vaccine Sales by Country (2023-2028) & (K Unit) 45
Table 52. North America Hepatitis A Vaccine Revenue by Country (2017-2022) & (US$ Million) 46
Table 53. North America Hepatitis A Vaccine Revenue by Country (2023-2028) & (US$ Million) 46
Table 54. Europe Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit) 49
Table 55. Europe Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit) 49
Table 56. Europe Hepatitis A Vaccine Revenue by Type (2017-2022) & (US$ Million) 50
Table 57. Europe Hepatitis A Vaccine Revenue by Type (2023-2028) & (US$ Million) 50
Table 58. Europe Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit) 51
Table 59. Europe Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit) 51
Table 60. Europe Hepatitis A Vaccine Sales by Country (2017-2022) & (K Unit) 52
Table 61. Europe Hepatitis A Vaccine Sales by Country (2023-2028) & (K Unit) 52
Table 62. Europe Hepatitis A Vaccine Revenue by Country (2017-2022) & (US$ Million) 53
Table 63. Europe Hepatitis A Vaccine Revenue by Country (2023-2028) & (US$ Million) 53
Table 64. Asia Pacific Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit) 58
Table 65. Asia Pacific Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit) 58
Table 66. Asia Pacific Hepatitis A Vaccine Revenue by Type (2017-2022) & (US$ Million) 59
Table 67. Asia Pacific Hepatitis A Vaccine Revenue by Type (2023-2028) & (US$ Million) 59
Table 68. Asia Pacific Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit) 60
Table 69. Asia Pacific Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit) 60
Table 70. Asia Pacific Hepatitis A Vaccine Sales by Region (2017-2022) & (K Unit) 61
Table 71. Asia Pacific Hepatitis A Vaccine Sales by Region (2023-2028) & (K Unit) 61
Table 72. Asia Pacific Hepatitis A Vaccine Revenue by Region (2017-2022) & (US$ Million) 62
Table 73. Asia Pacific Hepatitis A Vaccine Revenue by Region (2023-2028) & (US$ Million) 63
Table 74. South America Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit) 67
Table 75. South America Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit) 67
Table 76. South America Hepatitis A Vaccine Revenue by Type (2017-2022) & (US$ Million) 68
Table 77. South America Hepatitis A Vaccine Revenue by Type (2023-2028) & (US$ Million) 68
Table 78. South America Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit) 69
Table 79. South America Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit) 69
Table 80. South America Hepatitis A Vaccine Sales by Country (2017-2022) & (K Unit) 70
Table 81. South America Hepatitis A Vaccine Sales by Country (2023-2028) & (K Unit) 70
Table 82. South America Hepatitis A Vaccine Revenue by Country (2017-2022) & (US$ Million) 71
Table 83. South America Hepatitis A Vaccine Revenue by Country (2023-2028) & (US$ Million) 71
Table 84. Middle East and Africa Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit) 73
Table 85. Middle East and Africa Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit) 73
Table 86. Middle East and Africa Hepatitis A Vaccine Revenue by Type (2017-2022) & (US$ Million) 74
Table 87. Middle East and Africa Hepatitis A Vaccine Revenue by Type (2023-2028) & (US$ Million) 74
Table 88. Middle East and Africa Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit) 75
Table 89. Middle East and Africa Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit) 75
Table 90. Middle East and Africa Hepatitis A Vaccine Sales by Country (2017-2022) & (K Unit) 76
Table 91. Middle East and Africa Hepatitis A Vaccine Sales by Country (2023-2028) & (K Unit) 77
Table 92. Middle East and Africa Hepatitis A Vaccine Revenue by Country (2017-2022) & (US$ Million) 77
Table 93. Middle East and Africa Hepatitis A Vaccine Revenue by Country (2023-2028) & (US$ Million) 78
Table 94. GSK Corporation Information 80
Table 95. GSK Description and Major Businesses 80
Table 96. GSK Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2022) 81
Table 97. GSK Hepatitis A Vaccine Product Introduction 81
Table 98. Merck Corporation Information 82
Table 99. Merck Description and Major Businesses 83
Table 100. Merck Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2022) 84
Table 101. Merck Hepatitis A Vaccine Product Introduction 84
Table 102. Merck Recent Developments 85
Table 103. Sanofi Corporation Information 86
Table 104. Sanofi Description and Major Businesses 87
Table 105. Sanofi Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2022) 87
Table 106. Sanofi Hepatitis A Vaccine Product Introduction 88
Table 107. Sanofi Recent Developments 89
Table 108. Sinovac Corporation Information 90
Table 109. Sinovac Description and Major Businesses 90
Table 110. Sinovac Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2022) 91
Table 111. Sinovac Hepatitis A Vaccine Product Introduction 91
Table 112. Sinovac Recent Developments 92
Table 113. Zhejiang Pukang Corporation Information 92
Table 114. Zhejiang Pukang Description and Major Businesses 93
Table 115. Zhejiang Pukang Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2022) 93
Table 116. Zhejiang Pukang Hepatitis A Vaccine Product Introduction 94
Table 117. Changchun Institute of Biological Corporation Information 94
Table 118. Changchun Institute of Biological Description and Major Businesses 95
Table 119. Changchun Institute of Biological Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2022) 96
Table 120. Changchun Institute of Biological Hepatitis A Vaccine Product Introduction 96
Table 121. KM Biologics Corporation Information 97
Table 122. KM Biologics Description and Major Businesses 97
Table 123. KM Biologics Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2022) 99
Table 124. KM Biologics Hepatitis A Vaccine Product Introduction 99
Table 125. KM Biologics Recent Developments 100
Table 126. IMBCAMS Corporation Information 101
Table 127. IMBCAMS Description and Major Businesses 101
Table 128. IMBCAMS Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2022) 102
Table 129. IMBCAMS Hepatitis A Vaccine Product Introduction 102
Table 130. AIM Vaccine Corporation Information 103
Table 131. AIM Vaccine Description and Major Businesses 104
Table 132. AIM Vaccine Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2022) 105
Table 133. AIM Vaccine Hepatitis A Vaccine Product Introduction 105
Table 134. AIM Vaccine Recent Developments 106
Table 135. Key Raw Materials Lists 109
Table 136. Raw Materials Key Suppliers Lists 109
Table 137. Hepatitis A Vaccine Distributors List 113
Table 138. Hepatitis A Vaccine Customers List 115
Table 139. Hepatitis A Vaccine Market Trends 118
Table 140. Hepatitis A Vaccine Market Drivers 118
Table 141. Hepatitis A Vaccine Market Challenges 119
Table 142. Hepatitis A Vaccine Market Restraints 120
Table 143. Research Programs/Design for This Report 123
Table 144. Key Data Information from Secondary Sources 126
Table 145. Key Data Information from Primary Sources 127
List of Figures
Figure 1. Hepatitis A Vaccine Product Picture 1
Figure 2. Global Hepatitis A Vaccine Market Size Share by Type, 2017-2028 (US$ Million) 2
Figure 3. Global Hepatitis A Vaccine Market Share by Type: 2021 3
Figure 4. Global Hepatitis A Vaccine Market Share by Type: 2028 3
Figure 5. Inactivated Vaccine Product Picture 4
Figure 6. Major Manufacturers of Inactivated Vaccine 4
Figure 7. Live Attenuated Vaccine Product Picture 5
Figure 8. Global Hepatitis A Vaccine Market Size Share by Application, 2017 -2028 (US$ Million) 6
Figure 9. Global Hepatitis A Vaccine Market Share by Application: 2021 7
Figure 10. Global Hepatitis A Vaccine Market Share by Application: 2021 & 2028 7
Figure 11. Hepatitis A Vaccine Report Years Considered 8
Figure 12. Global Hepatitis A Vaccine Sales 2017-2028 (K Unit) 9
Figure 13. Global Hepatitis A Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028 10
Figure 14. Global Hepatitis A Vaccine Revenue 2017-2028 (US$ Million) 11
Figure 15. Global Hepatitis A Vaccine Revenue Market Share by Region in Percentage: 2021 12
Figure 16. Global Hepatitis A Vaccine Revenue Market Share by Region in Percentage: 2028 12
Figure 17. Global Hepatitis A Vaccine Sales Market Share by Region (2017-2022) 14
Figure 18. Global Hepatitis A Vaccine Sales Market Share by Region (2023-2028) 15
Figure 19. North America Hepatitis A Vaccine Sales YoY (2017-2028) & (K Unit) 17
Figure 20. North America Hepatitis A Vaccine Revenue YoY (2017-2028) & (US$ Million) 17
Figure 21. Europe Hepatitis A Vaccine Sales YoY (2017-2028) & (K Unit) 18
Figure 22. Europe Hepatitis A Vaccine Revenue YoY (2017-2028) & (US$ Million) 18
Figure 23. Asia-Pacific Hepatitis A Vaccine Sales YoY (2017-2028) & (K Unit) 19
Figure 24. Asia-Pacific Hepatitis A Vaccine Revenue YoY (2017-2028) & (US$ Million) 19
Figure 25. South America Hepatitis A Vaccine Sales YoY (2017-2028) & (K Unit) 20
Figure 26. South America Hepatitis A Vaccine Revenue YoY (2017-2028) & (US$ Million) 20
Figure 27. Middle East & Africa Hepatitis A Vaccine Sales YoY (2017-2028) & (K Unit) 21
Figure 28. Middle East & Africa Hepatitis A Vaccine Revenue YoY (2017-2028) & (US$ Million) 22
Figure 29. The Hepatitis A Vaccine Market Share of Top Largest Manufacturers Around the World in 2021 25
Figure 30. The Top Largest Manufacturers of Hepatitis A Vaccine in the World: Market Share by Hepatitis A Vaccine Revenue in 2021 27
Figure 31. Global Hepatitis A Vaccine Sales Market Share by Type (2017-2028) 34
Figure 32. Global Hepatitis A Vaccine Revenue Market Share by Type (2017-2028) 36
Figure 33. Global Hepatitis A Vaccine Sales Market Share by Application (2017-2028) 38
Figure 34. Global Hepatitis A Vaccine Revenue Market Share by Application (2017-2028) 40
Figure 35. North America Hepatitis A Vaccine Sales Market Share by Type (2017-2028) 42
Figure 36. North America Hepatitis A Vaccine Revenue Market Share by Type (2017-2028) 43
Figure 37. North America Hepatitis A Vaccine Sales Market Share by Application (2017-2028) 44
Figure 38. North America Hepatitis A Vaccine Sales Share by Country (2017-2028) 45
Figure 39. North America Hepatitis A Vaccine Revenue Share by Country (2017-2028) 46
Figure 40. U.S. Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million) 47
Figure 41. Canada Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million) 47
Figure 42. Mexico Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million) 48
Figure 43. Europe Hepatitis A Vaccine Sales Market Share by Type (2017-2028) 49
Figure 44. Europe Hepatitis A Vaccine Revenue Market Share by Type (2017-2028) 50
Figure 45. Europe Hepatitis A Vaccine Sales Market Share by Application (2017-2028) 51
Figure 46. Europe Hepatitis A Vaccine Sales Share by Country (2017-2028) 53
Figure 47. Europe Hepatitis A Vaccine Revenue Share by Country (2017-2028) 54
Figure 48. Germany Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million) 55
Figure 49. France Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million) 55
Figure 50. U.K. Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million) 56
Figure 51. Italy Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million) 56
Figure 52. Russia Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million) 57
Figure 53. Asia Pacific Hepatitis A Vaccine Sales Market Share by Type (2017-2028) 58
Figure 54. Asia Pacific Hepatitis A Vaccine Revenue Market Share by Type (2017-2028) 59
Figure 55. Asia Pacific Hepatitis A Vaccine Sales Market Share by Application (2017-2028) 60
Figure 56. Asia Pacific Hepatitis A Vaccine Sales Share by Region (2017-2028) 62
Figure 57. Asia Pacific Hepatitis A Vaccine Revenue Share by Region (2017-2028) 63
Figure 58. China Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million) 64
Figure 59. Japan Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million) 64
Figure 60. South Korea Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million) 65
Figure 61. India Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million) 65
Figure 62. Australia Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million) 66
Figure 63. Southeast Asia Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million) 66
Figure 64. South America Hepatitis A Vaccine Sales Market Share by Type (2017-2028) 67
Figure 65. South America Hepatitis A Vaccine Revenue Market Share by Type (2017-2028) 68
Figure 66. South America Hepatitis A Vaccine Sales Market Share by Application (2017-2028) 70
Figure 67. South America Hepatitis A Vaccine Sales Share by Country (2017-2028) 71
Figure 68. South America Hepatitis A Vaccine Revenue Share by Country (2017-2028) 72
Figure 69. Brazil Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million) 72
Figure 70. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Type (2017-2028) 74
Figure 71. Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Type (2017-2028) 75
Figure 72. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Application (2017-2028) 76
Figure 73. Middle East and Africa Hepatitis A Vaccine Sales Share by Country (2017-2028) 77
Figure 74. Middle East Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million) 78
Figure 75. Africa Hepatitis A Vaccine Revenue (2017-2028) & (US$ Million) 79
Figure 76. Hepatitis A Vaccine Value Chain 108
Figure 77. Hepatitis A Vaccine Production Process 111
Figure 78. Channels of Distribution 112
Figure 79. Distributors Profiles 114
Figure 80. Bottom-up and Top-down Approaches for This Report 125
Figure 81. Data Triangulation 126
Figure 82. Key Executives Interviewed 128

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Hepatitis A Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 89

According to our LPI (LP Information) latest study, the global Hepatitis A Vaccine market size was valued at US$ 690.5 million in 2023. With growing demand in downstream market, the Hepatitis A Vaccine is forecast to a readjusted size of US$ 810.9 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Hepatitis A Vaccine market. Hepatitis A Vaccine are expected to show stable growth in the future market. However, produc......

Global Human Hepatitis B Immunoglobulin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 127

Market Overview of Global Human Hepatitis B Immunoglobulin market: According to our latest research, the global Human Hepatitis B Immunoglobulin market looks promising in the next 5 years. As of 2022, the global Human Hepatitis B Immunoglobulin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensiv......

Global Hepatitis A Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 85

According to our (Global Info Research) latest study, the global Hepatitis A Vaccine market size was valued at USD 726.3 million in 2023 and is forecast to a readjusted size of USD 842.5 million by 2030 with a CAGR of 2.1% during review period. Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currentl......

Global Hepatitis A Vaccine Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117

Report Overview: Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 ye......

Global Thymosin a1 Professional Survey Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 103

Thymosin ?? is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their ......

Global Thymosin a1 Market Research Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 136

Thymosin ?? is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their ......

Global Hepatitis B Immune Globulin Market Research Report 2023

Published: 06-Nov-2023        Price: US 2900 Onwards        Pages: 85

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hepatitis B Immune Globulin market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - ADMA Biologics - Bio Products Laboratory - Grifols - Biotest AG - CSL Behring - FFF Enterprises - Cleveland Clinic Seg......

Global Sofosbuvir Market Research Report 2023

Published: 31-Oct-2023        Price: US 2900 Onwards        Pages: 94

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sofosbuvir market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Teva Pharmaceutical Industries Ltd - DONG BANG FUTURE TECH & LIFE CO., LTD - Beaukev Pharma International Pvt.Ltd - DEAFARMA - Tecoland - Anhui HaiKang Pha......

Global Hepatitis A Vaccine Market Insights, Forecast to 2029

Published: 22-Sep-2023        Price: US 4900 Onwards        Pages: 97

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs